Understanding Osler-Weber-Rendu Syndrome (HHT): Causes, Symptoms, and Life Expectancy

What is Osler-Weber-Rendu Syndrome (HHT)? Osler-Weber-Rendu syndrome, also known as Hereditary Hemorrhagic Telangiectasia (HHT), is a rare genetic disorder that affects the development of blood vessels. Instead of forming normal capillaries, individuals with HHT develop abnormal blood vessels called arteriovenous malformations (AVMs). These AVMs can occur in various parts of the body, including the skin, mucous membranes, lungs, brain, and liver. The absence of capillaries in these AVMs means that blood flows directly from arteries to veins at high pressure, making these vessels fragile and prone to rupture. While HHT is a genetic condition, its prevalence is estimated to be around 1 in 5,000 people worldwide. However, the actual number might be higher as many individuals may have mild symptoms or no symptoms at all, remaining undiagnosed. HHT can affect people of all genders and ethnicities. Symptoms of Osler-Weber-Rendu Syndrome The symptoms of HHT can vary significantly from person to person, ranging from mild to severe. The most common and often the first noticeable symptom is: Recurrent Nosebleeds (Epistaxis): Frequent and persistent nosebleeds are a hallmark sign of HHT. These occur due to the formation of small, fragile blood vessels (telangiectases) in the nasal lining. While troublesome, these are typically not life-threatening on their own but require medical attention. Other potential symptoms and complications include: Gastrointestinal Bleeding: AVMs in the stomach or intestines can lead to chronic bleeding, resulting in anemia and fatigue. This can be a significant concern and, in some cases, may be associated with higher mortality. Pulmonary AVMs: Abnormal blood vessels in the lungs can lead to shortness of breath, fatigue, and a higher risk of stroke or brain abscess if blood clots travel to the brain. Cerebral AVMs: AVMs in the brain can cause symptoms like headaches, seizures, or even life-threatening hemorrhages (strokes). Liver AVMs: These can cause symptoms such as high-output heart failure, abdominal pain, or jaundice. Skin and Mucous Membrane Telangiectasias: Small, red, spider-like spots may appear on the face, lips, tongue, and hands. Causes of Osler-Weber-Rendu Syndrome HHT is primarily a genetic disorder, meaning it is inherited. It is caused by mutations in specific genes that are responsible for the proper formation of blood vessels. The most commonly implicated genes are: ENG ACVRL1 (also known as ALK1) SMAD4 In most cases (about 90%), HHT is inherited in an autosomal dominant pattern. This means that if one parent has the condition, each child has a 50% chance of inheriting the mutated gene and developing HHT. In about 10% of cases, the mutation occurs spontaneously (de novo) in an individual with no family history of the condition. Diagnosis of Osler-Weber-Rendu Syndrome Diagnosing HHT involves a combination of clinical evaluation, family history, and diagnostic tests. Doctors often use the CURAÇAO criteria, which include the presence of: Spontaneous, recurrent nosebleeds Telangiectasias on the skin and mucous membranes Visceral AVMs (in the lungs, liver, brain, or gastrointestinal tract) First-degree relative with HHT If an individual meets at least three of these criteria, they are usually diagnosed with HHT. Diagnostic tools may include: Imaging studies: Such as CT scans, MRI scans, or angiography to detect AVMs in the brain, lungs, or liver. Genetic testing: To identify mutations in the genes associated with HHT. Endoscopy: To examine the gastrointestinal tract for bleeding sources. Treatment and Management While there is no cure for HHT, various treatments aim to manage symptoms, prevent complications, and improve the quality of life. Management strategies depend on the location and severity of the AVMs and bleeding. For Nosebleeds: Treatments can include nasal sprays, cauterization (sealing blood vessels), septal dermoplasty (surgical repair of the nasal lining), or embolization (blocking abnormal blood vessels). For Gastrointestinal Bleeding: Iron supplements are crucial to manage anemia. In severe cases, endoscopic treatments or surgery may be necessary to stop bleeding. For Pulmonary AVMs: These are often treated with embolization to reduce the risk of stroke and other complications. Regular screening is vital. For Cerebral AVMs: Treatment options include embolization, surgery, or stereotactic radiosurgery, depending on the size and location of the AVM. For Liver AVMs: Treatment may involve embolization or medication to manage heart failure symptoms. Regular medical follow-ups and screenings are essential for individuals with HHT to monitor existing AVMs and detect new ones. Is Osler-Weber-Rendu Syndrome Life-Threatening? Osler-Weber-Rendu syndrome can be life-threatening, but this is not the case for most individuals diagnosed with the condition. The risk of life-threatening complications arises primarily from uncontrolled bleeding due to the rupture of AVMs in vital organs like the brain, lungs, or liver. A ruptured AVM in these areas can lead to severe hemorrhages, strokes, brain abscesses, or heart failure. However, with proper medical monitoring, regular screenings, and timely treatment, the outlook for people with HHT is generally good. Studies have shown that individuals who receive consistent care and screening often have a life expectancy comparable to the general population. For instance, a study in Denmark found that the life expectancy for individuals with HHT was only slightly lower than the control group, and the difference was not statistically significant. The risk is higher for those who are unaware they have the condition or do not receive regular medical attention. Early diagnosis and proactive management significantly reduce the likelihood of severe, life-threatening complications. Prevention and When to Consult a Doctor Since HHT is a genetic disorder, it cannot be prevented. However, its complications can be managed and minimized through early detection and consistent

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.